- Bedoelde u
- hospitalisation
Zoekresultaten - 14 results
Surveillance of Bloodstream Infections in Belgian Hospitals- Annual report 2023, Data up to and including 2022
show a hospital-associated bloodstream infection (HABSI) cumulative incidence of 5.4 patients with HABSI per 1,000 hospitalisations, and a HABSI incidence density of 9.2 episodes per 10,000 patient-days ...
Surveillance of Bloodstream Infections in Belgian Hospitals- Annual report 2023, Data up to and including 2022
(NSIH- SEP) show a hospital-associated bloodstream infection (HABSI) cumulative incidence of 5.4 patients with HABSI per 1,000 hospitalisations, and a HABSI incidence density of 9.2 episodes per 10,000 ...
Multinational collaboration in solving a European Braenderup outbreak linked to imported melons, 2021.
Braenderup outbreak cases (n = 348) had been reported from 12 countries in the European Union/European Economic Area (EU / EEA) and the United Kingdom (UK), including 68 hospitalised cases. With support from ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Publication Type: Peer reviewed scientific article Authors: Rose, Angela MC; Nicolay, Nathalie; Sandonis Martín, Virginia; Mazagatos, Clara; Petrović, Goranka; Niessen, F Annabel; Machado, Ausenda; Launay, Odile; Sarah Denayer; Seyler, Lucie; Baruch, Joaq ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
Publication Type: Peer reviewed scientific article Authors: Rose, Angela MC; Nicolay, Nathalie; Sandonis Martín, Virginia; Mazagatos, Clara; Petrović, Goranka; Baruch, Joaquin; Sarah Denayer; Seyler, Lucie; Domegan, Lisa; Launay, Odile; Machado, Ausenda; ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Humans REGISTRIES Vaccine Efficacy Abstract: BACKGROUND: Within the ECDC- VEBIS project, we prospectively monitored vaccine effectiveness (VE) against COVID-19 hospitalisation and COVID-19-related death ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
effectiveness (VE) in participating European countries since early 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory infection ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
SARS-CoV-2 in hospitalised severe acute respiratory illness (SARI) patients ≥ 20 years, combining data from these networks during Alpha (March-June)- and Delta (June-December)-dominant periods, ...
Aetiological and prognostic roles of frailty, multimorbidity and socioeconomic characteristics in the development of SARS-CoV-2 health outcomes: protocol for systematic reviews of population-based studies
infection probability, hospitalisation, intensive care unit (ICU) admission, mechanical ventilation and COVID-19 related mortality among general population and (2) to investigate the prognostic roles of ...
Surveillance épidémiologique de la rougeole (Morbillivirus)- 2022
contamination en Belgique. Les autres cas de rougeole étaient des cas isolés dont la source de contamination n’est pas connue. • Pour un des 8 cas aigus enregistrés, une hospitalisation s’est avérée nécessaire. ...